Global DNA Methylation Analysis Service Market Growth (Status and Outlook) 2024-2030

Global DNA Methylation Analysis Service Market Growth (Status and Outlook) 2024-2030

Product Code:1242421

Published Date: Dec 04,2024

Pages: 133

Region: Global

Category: Medical Care

PDF DOWNLOAD

GET FREE SAMPLE

CUSTOMIZE REQUEST

PDF DOWNLOAD

GET FREE SAMPLE

CUSTOMIZE REQUEST

SELECT A FORMAT

ADD TO BASKET

BUY NOW

Provide comprehensive and accurate analysis and reports according to your exact requirements

Provide comprehensive and accurate analysis and reports according to your exact requirements

CONTACT US

The global DNA Methylation Analysis Service market size is predicted to grow from US$ 567 million in 2024 to US$ 1009 million in 2030; it is expected to grow at a CAGR of 10.1% from 2024 to 2030.

DNA methylation analysis service refers to a laboratory or research service that studies the addition of methyl groups to the DNA molecule, particularly to the cytosine base in CpG dinucleotides. This epigenetic modification can regulate gene expression without changing the DNA sequence itself, influencing cellular processes and potentially contributing to diseases like cancer. The service typically involves high-throughput techniques such as bisulfite sequencing, methylation-specific PCR, or microarrays to examine DNA methylation patterns in specific genes or across the entire genome. The analysis provides insights into gene regulation, development, and disease mechanisms, and is often used in research, clinical diagnostics, and drug development. 
United States market for DNA Methylation Analysis Service is estimated to increase from US$ million in 2023 to US$ million by 2030, at a CAGR of % from 2024 through 2030.

China market for DNA Methylation Analysis Service is estimated to increase from US$ million in 2023 to US$ million by 2030, at a CAGR of % from 2024 through 2030.

Europe market for DNA Methylation Analysis Service is estimated to increase from US$ million in 2023 to US$ million by 2030, at a CAGR of % from 2024 through 2030.

Global key DNA Methylation Analysis Service players cover EpigenDx, Creative Biogene, Creative BioMart, CD Genomics, Zymo Research, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2023.

LPI (LP Information)' newest research report, the “DNA Methylation Analysis Service Industry Forecast” looks at past sales and reviews total world DNA Methylation Analysis Service sales in 2023, providing a comprehensive analysis by region and market sector of projected DNA Methylation Analysis Service sales for 2024 through 2030. With DNA Methylation Analysis Service sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world DNA Methylation Analysis Service industry.

This Insight Report provides a comprehensive analysis of the global DNA Methylation Analysis Service landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on DNA Methylation Analysis Service portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global DNA Methylation Analysis Service market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for DNA Methylation Analysis Service and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global DNA Methylation Analysis Service.

This report presents a comprehensive overview, market shares, and growth opportunities of DNA Methylation Analysis Service market by product type, application, key players and key regions and countries.

Segmentation by Type:
    Bisulfite Conversion-Based Analysis
    Enzyme-Based Analysis
    Next-Generation Sequencing (NGS)-Based Methylation Analysis
    Others

Segmentation by Application:
    Oncology
    Neurology
    Immunology
    Others

This report also splits the market by region:
    Americas
        United States
        Canada
        Mexico
        Brazil
    APAC
        China
        Japan
        Korea
        Southeast Asia
        India
        Australia
    Europe
        Germany
        France
        UK
        Italy
        Russia
    Middle East & Africa
        Egypt
        South Africa
        Israel
        Turkey
        GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
    EpigenDx
    Creative Biogene
    Creative BioMart
    CD Genomics
    Zymo Research
    Active Motif
    EpiGentek
    ACGT
    Nordic Biosite
    Sampled
    Hologic Diagenode
    CeGaT
    Génome Québec
    Celemics
    PacBio
    Epistem
    Illumina
    Wasatch Biolabs
    EpiGenie
    Thermo Fisher